ACCELERATING ACTION ON TB TOWARDS ACHIEVING 40X22

USAID leads the U.S. Government’s global tuberculosis (TB) efforts, working with agencies and partners around the world to reach every person with TB, cure those in need of treatment, and prevent the spread of new infections.

In September 2018, the United Nations General Assembly High Level Meeting (UNHLM) on TB set the stage for high-level attention and action on TB. This meeting established the ambitious target of diagnosing and enrolling an additional 40 million people on TB treatment by 2022 (commonly referred to as 40x22), with a focus on countries with the highest TB burden, and enrolling 30 million on TB preventive therapy (commonly referred to as 30x22).

USAID supports countries in reaching the global targets of diagnosing and enrolling 40 million people on TB treatment and enrolling 30 million on TB preventive therapy by 2022.

THE GLOBAL ACCELERATOR TO END TB

To help achieve these targets, at the 2018 UNHLM former USAID Administrator Mark Green announced the Agency’s new TB business model – the Global Accelerator to End Tuberculosis. The Accelerator is designed to increase investments from the public and private sectors to end the TB epidemic, while simultaneously building local commitment and capacity to achieve the goals set forth at the UNHLM. It focuses on 23 countries with high burdens of TB where the Agency can align with local communities and partners to deliver performance-based results toward the global target.

The Accelerator ensures that USAID is fighting to end TB efficiently and effectively by building local commitment and capacity with a focus on locally generated solutions that tailor the Agency’s TB response and combat stigma and discrimination.

To ensure the Accelerator’s effectiveness and increased transparency, the process relies on standardized data-collection that aligns with the targets of the UNHLM and covers critical TB technical areas. Through redefining our development relationship with partner governments, strengthening local institutions, and promoting systemic change, the Accelerator focuses on three key areas to support reaching national TB targets:

Partnership Statements
USAID Missions signed Partnership Statements with Ministries of Health in USAID’s priority countries for TB. These statements support increased collaboration and coordination with interventions to reach the targets of the UNHLM. Signed Partnership Statements are available online here.

Focused Technical Support
USAID builds the capacity of National TB Programs through direct support to improve systems and expand interventions for more sustainable and focused TB programming, including by embedding senior-level TB technical advisors and developing and managing TB commitment grants.

Locally Generated Solutions
USAID invests directly in local organizations to drive community-generated results to improve the diagnosis, treatment, and prevention of TB.